ArticleOncotarget2018

[Neratinib + Valproate] exposure permanently reduces ERBB1 and RAS expression in 4T1 mammary tumors and enhances M1 macrophage infiltration.

Laurence Booth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.